MedTrace Logo

Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section

NCT02571881 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2023-03-16

No results posted yet for this study

Summary

Constipation is common in pregnant women. Surgery, anaesthesia and opioid analgesics may further impair bowel function. The aim of the present study was to evaluate if oxycodone-naloxone combination compared to oxycodone reduced bowel dysfunction in patients undergoing caesarean section.

Conditions

Interventions

PROCEDURE

Caesarean section

After caesarean section oxycodone or oxycodone-naloxone prolonged release tablet twice a day is started for pain medication

DRUG

Oxycodone

DRUG

oxycodone-naloxone

Sponsors & Collaborators

  • Admescope Ltd

    collaborator INDUSTRY

  • Kuopio University Hospital

    lead OTHER

Principal Investigators

  • Merja Kokki, MD, PhD · Kuopio University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02571881 on ClinicalTrials.gov